We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TAP Appoints New Non-Executive Director To Strengthen TAP’s Management Team in the Field of Cell Based Therapeutics

News   Jan 14, 2011

 
TAP Appoints New Non-Executive Director To Strengthen TAP’s Management Team in the Field of Cell Based Therapeutics
 
 
 

RELATED ARTICLES

3D Heart Printed Using Patient's Own Tissue

News

The engineered heart completely matches the immunological, cellular, biochemical and anatomical properties of the patient.

READ MORE

Could Persistent CD30 Signaling Lead to Blood Cancers?

News

Researchers have developed a mouse model to investigate whether persistent CD30 signaling leads to the development of blood cancers.

READ MORE

First Off-the-Shelf Immunotherapy Clinical Trial Launched

News

Fate Therapeutics, in collaboration with UC San Diego researchers, developed the first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE